huahaipharm(SH:600521) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-09-13 03:54Core Viewpoint - The company, Zhejiang Huahai Pharmaceutical Co., Ltd., is set to hold an investor briefing on September 22, 2025, to discuss its 2025 semi-annual performance and financial results, allowing for interactive communication with investors [2][3][4]. Group 1: Meeting Details - The investor briefing will take place on September 22, 2025, from 16:00 to 17:00 [4]. - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, accessible online [4]. - The meeting will be conducted in an interactive online format, enabling real-time communication with investors [3][4]. Group 2: Participation Information - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [6]. - Questions from investors can be submitted between September 15 and September 19, 2025, through the Roadshow Center's website or via the company's email [6][5]. - The company will address commonly asked questions during the briefing [6]. Group 3: Key Personnel - Key participants in the briefing include the company's President Chen Baohua, Vice President and Secretary of the Board Zhu Yonghua, CFO Zhang Mei, and Independent Director Deng Chuan [5]. Group 4: Contact Information - For inquiries, investors can contact Jin Min or Wang Huiting via phone or email [7].